Using virtual reality to recover from a cerebro-vascular accident

May 19, 2011 By Cécilia Carron in Neuroscience
Using virtual reality to recover from a cerebro-vascular accident

Enlarge

It’s possible to regain mobility in your arms using “Nano” after a cerebro-vascular accident (CVA). Developed by MindMaze, an EPFL spin-off company, this device can be used every day at home.

Portable, accessible and easy to use, the “Nano” represents a small revolution in neuromuscular rehabilitation after a cerebro-vascular accident. This therapy, using equipment that fits into a small briefcase, works using . It consists of a screen, a webcam, a pair of dark glasses, a helmet fitted with electrodes, and a glove: the patient puts on the equipment, presses “ON” and the session starts. This ease of use makes it suitable for daily practice at home. “The first few weeks are known to be the most important for recovery. This is when many people give up”, emphasizes Tej Tadi, founder of MindMaze, the start-up based at The Garage – EPFL’s breeding-ground for new companies – which is developing the "Nano".

This video is not supported by your browser at this time.

Making progress using an avatar

The physiotherapy is based on a simple principle: observing the scene that is supposed to represent us is enough, gradually, to reactivate the damaged region of the brain. When the patient moves his active hand, he actually sees the 3D avatar of his disabled limb moving through his glasses. This activates a region of the cortex adjacent to the damaged area, which then slowly takes over.

The exercises are then carried out with the disabled limb: stretching the arm, picking up an object, or pointing at something.

Doctors can access real-time data

The electrodes fitted to the helmet provide constant data on the brain’s activity. Transmitted via the internet with a 3D-image of the brain, these enable the medical staff to see the changes in the patient’s brain directly, while remaining at the hospital, and to give him instructions. The patient can follow his progress through the display of this data in the form of a graphic.

The system is due to be marketed by the end of this year. It’s currently in the preclinical trials stage at the Vaud canton’s university hospital (CHUV). For now it would seem that mobility is also being recovered more rapidly than with the programs currently on offer.

Every year 10,000 people in Switzerland and 12 million worldwide are affected by a CVA. “We began by suggesting a device designed to rehabilitate the arm, because this is the main handicap for 75% of patients who have undergone a CVA”, emphasizes Tej Tadi, who developed this technology during his doctoral work at the EPFL Laboratory of Cognitive Neuroscience.

An EPFL spin-off company, the MindMaze start-up has already won several awards, including the Venture Leaders in 2010 and PERL (Prix Entreprendre Région Lausanne), the prize awarded by the Association of communes of the Lausanne region, in March last year. The company’s founder plans to put the first device on sale in mid- 2012. The Swiss and German markets, where the company will begin operations, are valued at 55 million francs. An international launch is planned for three years from now.

Provided by Ecole Polytechnique Federale de Lausanne

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts
  • A question about drug tolerance
    created19 hours ago
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Persistent sensory experience is good for aging brain

Despite a long-held scientific belief that much of the wiring of the brain is fixed by the time of adolescence, a new study shows that changes in sensory experience can cause massive rewiring of the brain, even as one ages. ...

Neuroscience created 1 hour ago | popularity not rated yet | comments 0

Boundary stops molecule right where it needs to be

A molecule responsible for the proper formation of a key portion of the nervous system finds its way to the proper place not because it is actively recruited, but instead because it can't go anywhere else.

Neuroscience created 1 hour ago | popularity not rated yet | comments 0 | with audio podcast

Locating ground zero: How the brain's emergency workers find the disaster area

Like emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by 'eating up' any cellular debris and dead or dying neurons. ...

Neuroscience created 1 hour ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Genetic 'reset switch' enables signaling pathway to induce multiple developmental outcomes for olfactory neurons

Within the nervous system, a handful of signaling pathways modulate development of a cornucopia of different neuronal subtypes. “Even small alterations in neuron differentiation pathways can disrupt subsequent ...

Neuroscience created 5 hours ago | popularity not rated yet | comments 0

The auditory cortex adapts agilely with concentration

The birth of sensory perception on the human cerebral cortex is yet to be fully explained. The different areas on the cortex function in cooperation, and no perception is the outcome of only one area working alone. In his ...

Neuroscience created 6 hours ago | popularity not rated yet | comments 0


Researchers identify protein necessary for behavioral flexibility

Researchers have identified a protein necessary to maintain behavioral flexibility, which allows us to modify our behaviors to adjust to circumstances that are similar, but not identical, to previous experiences. Their findings, ...

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

Researcher calls for new approach to regulating probiotics

In today's Nature scientific journal Dr. Gregor Reid, Director of the Canadian R&D Centre for Probiotics at Lawson Health Research Institute and a scientist at Western University, calls for a Category Tree system to be imp ...

Male fertility genes discovered

A new study has revealed previously undiscovered genetic variants that influence fertility in men. The findings, published by Cell Press on May 24th in the American Journal of Human Genetics, shed much-needed light on hum ...

Knowing genetic makeup may not significantly improve disease risk prediction

Harvard School of Public Health (HSPH) researchers have found that detailed knowledge about your genetic makeup—the interplay between genetic variants and other genetic variants, or between genetic variants and environmental ...

A boost in microRNA may protect against sepsis and other inflammatory diseases

Acute inflammatory diseases, such as sepsis, as well as chronic inflammatory diseases like diabetes and arthritis, develop as a result of sustained inflammation of the blood vessel wall. Researchers at Brigham and Women's ...